Taikang Asset Management (HK)’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.5M Buy
45,946
+13,666
+42% +$4.49M 1.34% 27
2025
Q4
$11.3M Buy
32,280
+1,647
+5% +$557K 1.12% 22
2025
Q3
$9.9M Buy
30,633
+13,638
+80% +$4.24M 1.11% 23
2025
Q2
$6.61M Buy
16,995
+1,022
+6% +$411K 0.85% 30
2025
Q1
$6.95M Buy
15,973
+2,186
+16% +$878K 0.95% 28
2024
Q4
$5.09M Buy
13,787
+4,673
+51% +$1.96M 0.75% 38
2024
Q3
$4.74M Buy
9,114
+4,707
+107% +$2.51M 0.5% 52
2024
Q2
$2.39M Buy
4,407
+2,307
+110% +$1.22M 0.37% 56
2024
Q1
$1.09M Buy
+2,100
New +$1.04M 0.23% 68

Other funds holding ELV

Taikang Asset Management (HK)'s ELV Position: Q1 2026 in Review

Taikang Asset Management (HK) increased its Elevance Health (ELV) stake by 42% in Q1 2026, buying an estimated $4.49M and bringing the position to 45,946 shares worth $13.5M. The position accounts for 1.34% of the portfolio, ranked #27.

Taikang Asset Management (HK) first reported a position in ELV in Q1 2024 and has held it in 9 quarters since. 1,463 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Taikang Asset Management (HK) held 45,946 shares of Elevance Health worth $13.5M as of Q1 2026.
  • Taikang Asset Management (HK) bought 13,666 Elevance Health shares in Q1 2026, an estimated $4.49M.
  • Elevance Health made up 1.34% of Taikang Asset Management (HK)'s portfolio in Q1 2026, its #27 holding.
  • Taikang Asset Management (HK) first reported a position in Elevance Health in Q1 2024 and has held it in 9 quarters since.
  • 1,463 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Taikang Asset Management (HK)'s 13F filing for Q1 2026, filed 14 May 2026.